<?xml version="1.0" ?>
<tei>
	<teiHeader>
		<fileDesc xml:id="55001365"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<docTitle>
	<titlePart>C-3 Epimers Can Account for a Significant Proportion of<lb/> Total Circulating 25-Hydroxyvitamin D in Infants,<lb/> Complicating Accurate Measurement and Interpretation<lb/> of Vitamin D Status<lb/></titlePart>
	</docTitle>

	<byline>
	<docAuthor>Ravinder J. Singh, Robert L. Taylor, G. Satyanarayana Reddy, and Stefan K. G. Grebe<lb/></docAuthor>
	</byline>

	<byline>
	<affiliation>Departments of Laboratory Medicine and Pathology(R.J.S., R.L.T., S.K.G.G.) and Medicine (S.K.G.G.), Mayo Clinic,</affiliation>
	</byline>
	
	<address><lb/> Rochester, Minnesota 55905; </address>

	<affiliation>and Epimer, LLC (G.S.R.),</affiliation>
	
	<address><lb/> Providence, Rhode Island 02906<lb/></address>
	
	<div type="abstract">Context: We have recently introduced liquid chromatography-<lb/>tandem mass spectrometry (LC-MS/MS) for 25-hydroxyvitamin D 2<lb/> (25OHD 2 ) and 25OHD 3 testing. During subsequent clinical use, we<lb/> identified significantly elevated results in some infants. We hypoth-<lb/>esized this might represent assay interference caused by C-3 epimers<lb/> of 25OHD 2 or 25OHD 3 .<lb/> Objective: Our aims were to 1) determine the prevalence of C-3<lb/> epimers of 25OHD 2 or 25OHD 3 in human serum, and 2) identify the<lb/> patient populations that might be affected.</div>

		</front>
	</text>
</tei>
